BrightInsight
Private Company
Total funding raised: $166M
Overview
BrightInsight is the leading global regulated digital health platform, serving top biopharma and medtech companies. Its cloud-based platform offers pre-built, compliant functionality to build and scale digital health products like drug companion apps and SaMD, reducing development time by 6-24 months. The company has demonstrated success with major partners like Sanofi and CSL Behring, driving improved patient adherence, engagement, and real-world data capture. BrightInsight operates as a private, revenue-generating platform company in a high-growth sector.
Technology Platform
Cloud-based regulated platform for building, launching, and scaling digital health solutions (SaMD, companion apps, connected devices). Includes pre-built compliant features, a real-time analytics dashboard engine, and global scalability with built-in security, privacy, and regulatory controls.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
BrightInsight operates in a competitive but specialized market. It faces potential competition from large cloud infrastructure providers (AWS, Google Cloud, Microsoft Azure) offering healthcare cloud services, as well as from other digital health platform and SaMD enablement companies. Its key competitive advantages are its first-mover status, deep focus on life sciences regulatory compliance, proven deployment scale with top clients, and a pre-built functionality library that significantly accelerates time-to-market.